253 related articles for article (PubMed ID: 10592810)
1. Screening for acyclovir-resistant herpes simplex virus isolates from clinical samples.
Mah IW; Kuo BI; Wei HY; Tsai CH; Liu WT
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Feb; 30(1):51-4. PubMed ID: 10592810
[TBL] [Abstract][Full Text] [Related]
2. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
[TBL] [Abstract][Full Text] [Related]
4. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
6. [Isolation of acyclovir-resistant strains of herpes simplex virus from clinical material].
L'vov ND; Andronova VL; Leont'eva NA; Galegov GA
Vopr Virusol; 1999; 44(6):247-9. PubMed ID: 10665057
[TBL] [Abstract][Full Text] [Related]
7. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
[TBL] [Abstract][Full Text] [Related]
8. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
[TBL] [Abstract][Full Text] [Related]
9. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
11. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates.
Shin YK; Cai GY; Weinberg A; Leary JJ; Levin MJ
J Clin Microbiol; 2001 Mar; 39(3):913-7. PubMed ID: 11230403
[TBL] [Abstract][Full Text] [Related]
12. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
[TBL] [Abstract][Full Text] [Related]
13. A retrospective, case-control study of acyclovir resistance in herpes simplex virus.
Malvy D; Treilhaud M; Bouée S; Crochard A; Vallée D; El Hasnaoui A; Aymard M;
Clin Infect Dis; 2005 Aug; 41(3):320-6. PubMed ID: 16007528
[TBL] [Abstract][Full Text] [Related]
14. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
[TBL] [Abstract][Full Text] [Related]
15. Factors that affect in vitro measurement of the susceptibility of herpes simplex virus to nucleoside analogues.
Weinberg A; Leary JJ; Sarisky RT; Levin MJ
J Clin Virol; 2007 Feb; 38(2):139-45. PubMed ID: 17169605
[TBL] [Abstract][Full Text] [Related]
16. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
[TBL] [Abstract][Full Text] [Related]
17. Acyclovir susceptibility of herpes simplex virus isolates from transplanted and nontransplanted patients in Rio de Janeiro, Brazil.
Varella RB; Guimarães MA; Guimarães AC; Atalla A; Nucci M; Ramos-e-Silva M
Skinmed; 2012; 10(4):208-11. PubMed ID: 23008937
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of HSV strains isolated before and after treatment with acyclovir.
Svennerholm B; Vahlne A; Löwhagen GB; Widell A; Lycke E
Scand J Infect Dis Suppl; 1985; 47():149-54. PubMed ID: 3006229
[TBL] [Abstract][Full Text] [Related]
19. A rapid antiviral drug test by enzyme-linked immunoassay.
Landini MP; Baldassarri B
Diagn Immunol; 1983; 1(4):284-7. PubMed ID: 6094087
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
